Navigating the Latest Data on NTRK-Targeted Therapies
Navigating the Latest Data on NTRK-Targeted Therapies is organized by Physicians' Education Resource, LLC (PER).
Release Date: January 31, 2023
Expiration Date: January 31, 2024
Description:
This Burst CME: Navigating the Latest Data on NTRK-Targeted Therapies is an interview-based program in which an expert discusses the current and emerging therapeutic options for patients with NTRK fusion–positive non–small cell lung cancer (NSCLC). Possible adverse events and mitigation strategies are also discussed. This will be presented in a multimedia format, including audio interviews integrated into text-based elements.
Learning Objectives:
Upon successful completion of this activity, you should be better prepared to:
• Describe testing methods and relevant targets that may be used to inform clinical decisions in patients with NSCLC and fusions of ROS1 or NTRK
• Interpret current efficacy and safety data from trials that leveraged precision testing strategies among patients with advanced NSCLC
• Explain emerging therapies that target ROS1 and NTRK in development to manage patients with advanced NSCLC.